SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001209191-19-055543
Filing Date
2019-11-06
Accepted
2019-11-06 17:27:07
Documents
1
Period of Report
2019-11-06

Document Format Files

Seq Description Document Type Size
1 FORM 3 SUBMISSION doc3.html 3  
1 FORM 3 SUBMISSION doc3.xml 3 4572
  Complete submission text file 0001209191-19-055543.txt   6192
Mailing Address TUBORG HAVNEVEJ 19 HELLERUP G7 2900
Business Address TUBORG HAVNEVEJ 19 HELLERUP G7 2900 45 8824 8824
Novo Holdings A/S (Reporting) CIK: 0001388325 (see all company filings)

State of Incorp.: G7 | Fiscal Year End: 1231
Type: 3 | Act: 34 | File No.: 001-39114 | Film No.: 191197378

Mailing Address 101 LINDENWOOD DRIVE SUITE 405 MALVERN PA 19355
Business Address 101 LINDENWOOD DRIVE SUITE 405 MALVERN PA 19355 610-725-1500
Galera Therapeutics, Inc. (Issuer) CIK: 0001563577 (see all company filings)

IRS No.: 461454898 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations